CoChat

Complement activation promoted by the lectin pathway mediates C3aR-dependent sarcoma progression and immunosuppression

Open access
Magrini, Elena, Di Marco, Sabrina, Mapelli, Sarah N., Perucchini, Chiara, Pasqualini, Fabio, Donato, Alessia, Guevara Lopez, Maria de la Luz, Carriero, Roberta, Ponzetta, Andrea, Colombo, Piergiuseppe, Cananzi, Ferdinando, Supino, Domenico, Reis, Edimara S., Peano, Clelia, Inforzato, Antonio, Jaillon, Sebastien, Doni, Andrea, Lambris, John D., Mantovani, Alberto, Garlanda, Cecilia · 2021 · Nature Cancer
Cited by 75

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Complement has emerged as a component of tumor-promoting inflammation. We conducted a systematic assessment of the role of complement activation and effector pathways in sarcomas. C3−/−, MBL1/2−/− and C4−/− mice showed reduced susceptibility to 3-methylcholanthrene sarcomagenesis and transplanted sarcomas, whereas C1q and factor B deficiency had marginal effects. Complement 3a receptor (C3aR), but not C5aR1 and C5aR2, deficiency mirrored the phenotype of C3−/− mice. C3 and C3aR deficiency were associated with reduced accumulation and functional skewing of tumor-associated macrophages, increased T-cell activation and response to anti-PD-1 therapy. Transcriptional profiling of sarcoma-infiltrating macrophages and monocytes revealed the enrichment of the major histocompatibility complex II–dependent antigen presentation pathway in C3-deficient cells. In patients, C3aR expression correlated with a macrophage population signature, and C3-deficiency-associated signatures predicted better clinical outcome. These results suggest that the lectin pathway and C3a–C3aR axis are key components of complement and macrophage-mediated sarcoma promotion and immunosuppression. Magrini et. al. study sarcoma development and antitumor immune response in complement-deficient murine hosts, demonstrating a role for the C3a–C3aR axis in promoting immunosuppressive macrophages.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s43018-021-00173-0

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 75

Metadata

Authors
Magrini, E., Di Marco, S., Mapelli, S. N., Perucchini, C., Pasqualini, F., Donato, A., Guevara Lopez, M. D. L. L., Carriero, R., Ponzetta, A., Colombo, P., Cananzi, F., Supino, D., Reis, E. S., Peano, C., Inforzato, A., Jaillon, S., Doni, A., Lambris, J. D., Mantovani, A., & Garlanda, C.
Venue
Nature Cancer
Published
2021-02-18
Volume
2
Issue
2
Pages
218-232
ISSN
2662-1347 (ISSN-L)
OpenAlex
W3130663327
Cited by
75
References
12
FWCI
3.79
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Complement activation promoted by the lectin pathway mediates C3aR-dependent sarcoma progression and immunosuppression. https://app.cochat.ai/papers/10.1038/s43018-021-00173-0
The paper
Magrini, E., Di Marco, S., Mapelli, S. N., Perucchini, C., Pasqualini, F., Donato, A., Guevara Lopez, M. D. L. L., Carriero, R., Ponzetta, A., Colombo, P., Cananzi, F., Supino, D., Reis, E. S., Peano, C., Inforzato, A., Jaillon, S., Doni, A., Lambris, J. D., Mantovani, A., & Garlanda, C. (2021). Complement activation promoted by the lectin pathway mediates C3aR-dependent sarcoma progression and immunosuppression. Nature Cancer. https://doi.org/10.1038/s43018-021-00173-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.